Laronze JY - Search Results

1

Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.

Laronze-Cochard M, Kim YM, Brassart B, Riou JF, Laronze JY, Sapi J. Laronze-Cochard M, et al. Among authors: laronze jy. Eur J Med Chem. 2009 Oct;44(10):3880-8. doi: 10.1016/j.ejmech.2009.04.021. Epub 2009 Apr 22. Eur J Med Chem. 2009. PMID: 19467742

2

Cytotoxic bis-3,4-dihydro-beta-carbolines and bis-beta-carbolines.

Jiang WQ, Charlet-Fagnère C, Sapi J, Laronze JY, Renard P, Pfeiffer B, Léonce S. Jiang WQ, et al. Among authors: laronze jy. J Enzyme Inhib Med Chem. 2002 Dec;17(6):369-74. doi: 10.1080/147563021000005631. J Enzyme Inhib Med Chem. 2002. PMID: 12683671

3

N-arylsulfonyl-2-vinyltryptamines as new 5-HT6 serotonin receptor ligands.

Raoul M, Patigny D, Fabis F, Dauphin F, Rault S, Sapi J, Laronze JY. Raoul M, et al. Among authors: laronze jy. J Enzyme Inhib Med Chem. 2006 Jun;21(3):251-60. doi: 10.1080/14756360600700285. J Enzyme Inhib Med Chem. 2006. PMID: 16918072

4

Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.

Ledour G, Moroy G, Rouffet M, Bourguet E, Guillaume D, Decarme M, Elmourabit H, Augé F, Alix AJ, Laronze JY, Bellon G, Hornebeck W, Sapi J. Ledour G, et al. Among authors: laronze jy. Bioorg Med Chem. 2008 Sep 15;16(18):8745-59. doi: 10.1016/j.bmc.2008.07.041. Epub 2008 Jul 20. Bioorg Med Chem. 2008. PMID: 18782669

5

[Synthesis of peptide and pseudo-peptide analogs of cholecystokinin].

Jeannin L, Sapi J, Cartier D, Laronze JY, Maigret B, Penke B. Jeannin L, et al. Among authors: laronze jy. Ann Pharm Fr. 1997;55(3):135-40. Ann Pharm Fr. 1997. PMID: 9239862 French.

6

Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives.

Augé F, Hornebeck W, Decarme M, Laronze JY. Augé F, et al. Among authors: laronze jy. Bioorg Med Chem Lett. 2003 May 19;13(10):1783-6. doi: 10.1016/s0960-894x(03)00214-2. Bioorg Med Chem Lett. 2003. PMID: 12729664

7

The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent.

Floquet N, Pasco S, Ramont L, Derreumaux P, Laronze JY, Nuzillard JM, Maquart FX, Alix AJ, Monboisse JC. Floquet N, et al. Among authors: laronze jy. J Biol Chem. 2004 Jan 16;279(3):2091-100. doi: 10.1074/jbc.M307736200. Epub 2003 Oct 28. J Biol Chem. 2004. PMID: 14583633 Free article.

8

A novel strategy for designing specific gelatinase A inhibitors: potential use to control tumor progression.

Augé F, Hornebeck W, Laronze JY. Augé F, et al. Among authors: laronze jy. Crit Rev Oncol Hematol. 2004 Mar;49(3):277-82. doi: 10.1016/j.critrevonc.2003.10.006. Crit Rev Oncol Hematol. 2004. PMID: 15036267 Review.

9

Collagen-binding domains of gelatinase A and thrombospondin-derived peptides impede endocytic clearance of active gelatinase A and promote HT1080 fibrosarcoma cell invasion.

Robinet A, Emonard H, Banyai L, Laronze JY, Patthy L, Hornebeck W, Bellon G. Robinet A, et al. Among authors: laronze jy. Life Sci. 2008 Feb 13;82(7-8):376-82. doi: 10.1016/j.lfs.2007.11.018. Epub 2007 Dec 5. Life Sci. 2008. PMID: 18222489

10

Non-covalent complexes between bis-beta-carbolines and double-stranded DNA: A study by electrospray ionization FT-ICR mass spectrometry (I).

Dong X, Xu Y, Afonso C, Jiang W, Laronze JY, Wen R, Tabet JC. Dong X, et al. Among authors: laronze jy. Bioorg Med Chem Lett. 2007 May 1;17(9):2549-53. doi: 10.1016/j.bmcl.2007.02.010. Epub 2007 Feb 7. Bioorg Med Chem Lett. 2007. PMID: 17368899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page